Overview

The Maintenance Therapy of Capecitabine of Advanced Gastric Cancer

Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
To confirm the efficacy and safety of XELOX with capecitabine maintenance in treatment of advanced gastric cancer (AGC)
Phase:
Phase 2
Details
Lead Sponsor:
The Second People's Hospital of Sichuan
Treatments:
Capecitabine
Oxaliplatin
Paclitaxel